GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Name: GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
Published: 2019
License: Public Domain

GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

esophageal-squamous-cell-carcinoma non-small-cell-lung-cancer triple-negative-breast-cancer

pancreatic adenocarcinoma, esophageal adenocarcinoma, esophageal squamous cell carcinoma, gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, triple negative breast cancer, castration-resistant prostate cancer, microsatellite stable colorectal cancer, non-small cell lung cancer, small-cell lung cancer, head and neck squamous cell carcinoma, urothelial carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 870624
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.